← Back to Clinical Trials
Recruiting NCT06321263

NCT06321263 Comparison of the Effects of Peripheral Muscle Training and Inspiratory Muscle Training in Geriatric Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06321263
Status Recruiting
Phase
Sponsor Biruni University
Condition Muscle Strength
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-03-25
Primary Completion 2024-09-27

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Peripheral Muscle Training and step aerobics trainingInspiratory Muscle Training and step aerobics training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-03-25 with a primary completion date of 2024-09-27.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In geriatric individuals, there is a decrease in muscle strength, muscle mass and physical performance with ageing. These physiological changes occurring in geriatric individuals make maintaining the physical activity necessary for a healthy life difficult. Weakness of respiratory muscles in geriatric individuals can increase the prevalence of diseases and disability. It has been shown in the literature that peripheral muscle training and inspiratory muscle training increase exercise capacity similarly. The effectiveness of moderate-intensity peripheral muscle training and inspiratory muscle training in sarcopenic geriatric individuals was compared and found to have similar effects on muscle strength. Our study aims to compare the effects of inspiratory and peripheral muscle training in addition to aerobic exercise on muscle strength, physical performance, respiratory muscle strength, functional capacity, sarcopenia, and quality of life.

Eligibility Criteria

Inclusion Criteria: * 65 years to 80 years (Older ), * Standardised Mini Mental Test score ≥ 20, * To walk 10 meters with or without an assistive device, * If the participants answered No all of the questions of The Physical Activity Readiness Questionnaire * Volunteering to participate in the study Exclusion Criteria: * With serious neurological and orthopedic problems that may prevent them from exercising, * With serious vision and hearing problems, * With a psychiatric disease, * With serious cardiac and pulmonary system diseases that may prevent them from exercising, * With vestibular system problems or medication use that may affect the vestibular system, * Smokers.

Contact & Investigator

Central Contact

Buket Akıncı, Ass.Prof.

✉ bakinci@biruni.edu.tr

📞 902124448276

Principal Investigator

Buket Akıncı, Ass.Prof.

STUDY DIRECTOR

Biruni University

Frequently Asked Questions

Who can join the NCT06321263 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 80 Years, studying Muscle Strength. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06321263 currently recruiting?

Yes, NCT06321263 is actively recruiting participants. Contact the research team at bakinci@biruni.edu.tr for enrollment information.

Where is the NCT06321263 trial being conducted?

This trial is being conducted at Çanakkale, Turkey (Türkiye).

Who is sponsoring the NCT06321263 clinical trial?

NCT06321263 is sponsored by Biruni University. The principal investigator is Buket Akıncı, Ass.Prof. at Biruni University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology